Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Soleno Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee(1) | |||||||||
| Fees to be Paid |
Equity | Common stock, par value $0.001 per share |
457(o) and 457(r) |
— | — | $150,000,000 | 0.00014760 | $22,140.00 | ||||||||
| Fees Previously Paid |
— | — | — | — | — | — | — | — | ||||||||
| Total Offering Amounts | $150,000,000 | $22,140.00 | ||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||
| Total Fee Offsets | — | |||||||||||||||
| Net Fee Due | $22,140.00 | |||||||||||||||
| (1) | Calculated in accordance with Rules 457(o) and 457(r) under the Securities Act of 1933, as amended (the “Securities Act”). In accordance with Rules 456(b) and 457(r) of the Securities Act, the registrant initially deferred payment of all of the registration fee for Registration Statement No. 333-276344 filed by the registrant on January 2, 2024. |